We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.01%
This Fund
S&P 500
This Quarter Est. Return
+6.37%
1 Year Est. Return
+62.01%
3 Year Est. Return
+164.15%
5 Year Est. Return
+274.12%
10 Year Est. Return
+2,470.02%
AUM
$1.11B
AUM Growth
+$52.8M
Cap. Flow
-$12.7M
Cap. Flow %
-1.14%
Top 10 Hldgs %
19.77%
Holding
2,152
New
581
Increased
526
Reduced
430
Closed
561

Sector Composition

Rank Sector Weight
1 Technology 16.1%
2 Healthcare 13.61%
3 Communication Services 11.16%
4 Consumer Discretionary 6.46%
5 Real Estate 6.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DSPG
1226
DELISTED
DSP Group Inc
DSPG
$29K ﹤0.01%
2,207
+1,707
+341% +$20.6K
ORIT
1227
DELISTED
Oritani Financial Corp. New
ORIT
$29K ﹤0.01%
+1,700
New +$27.9K
UBNK
1228
DELISTED
United Financial Bancorp, Inc.
UBNK
$29K ﹤0.01%
1,600
+900
+129% +$15.6K
PHIIK
1229
DELISTED
PHI, Inc. Non-Voting Common Stock
PHIIK
$29K ﹤0.01%
2,500
-2,511
-50% -$27.3K
AVB icon
1230
AvalonBay Communities
AVB
$27B
$28K ﹤0.01%
+159
New +$29.8K
KOP icon
1231
Koppers
KOP
$1,000M
$28K ﹤0.01%
600
+100
+20% +$3.89K
LAB icon
1232
Standard BioTools
LAB
$321M
$28K ﹤0.01%
5,595
+2,959
+112% +$12.4K
PPC icon
1233
Pilgrim's Pride
PPC
$6.42B
$28K ﹤0.01%
+1,000
New +$26.3K
VNET
1234
VNET Group
VNET
$2.06B
$28K ﹤0.01%
+5,000
New +$24.9K
ITCI
1235
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$28K ﹤0.01%
1,762
-2,953
-63% -$43.3K
ISEE
1236
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$28K ﹤0.01%
10,000
+800
+9% +$2.16K
ATNI icon
1237
ATN International
ATNI
$387M
$27K ﹤0.01%
+517
New +$30.9K
KURA icon
1238
Kura Oncology
KURA
$841M
$27K ﹤0.01%
+1,800
New +$16.9K
LZB icon
1239
La-Z-Boy
LZB
$1.67B
$27K ﹤0.01%
1,000
-5,200
-84% -$152K
SIG icon
1240
Signet Jewelers
SIG
$3.78B
$27K ﹤0.01%
+400
New +$24.6K
TTGT icon
1241
TechTarget
TTGT
$317M
$27K ﹤0.01%
+2,300
New +$23.5K
VNDA icon
1242
Vanda Pharmaceuticals
VNDA
$321M
$27K ﹤0.01%
1,523
+193
+15% +$3.23K
SHLD
1243
DELISTED
Sears Holding Corporation
SHLD
$27K ﹤0.01%
+3,700
New +$30.4K
AVY icon
1244
Avery Dennison
AVY
$13.3B
$26K ﹤0.01%
266
+11
+4% +$1.03K
DBI icon
1245
PUT
Designer Brands
DBI
$336M
$26K ﹤0.01%
+1,200
New +$22.1K
ENTA icon
1246
Enanta Pharmaceuticals
ENTA
$387M
$26K ﹤0.01%
558
-146
-21% -$5.87K
WW
1247
DELISTED
WW International
WW
$26K ﹤0.01%
+600
New +$24.9K
XBI icon
1248
PUT
State Street SPDR S&P Biotech ETF
XBI
$9.92B
$26K ﹤0.01%
300
-111,300
-100% -$8.92M
MIME
1249
DELISTED
Mimecast Limited
MIME
$26K ﹤0.01%
930
+192
+26% +$5.28K
LOXO
1250
DELISTED
Loxo Oncology, Inc
LOXO
$26K ﹤0.01%
279
+9
+3% +$699

Similar funds

Prelude Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Prelude Capital Management held 2,152 positions worth $1.11B, up 5% from $1.06B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Prelude Capital Management's Q3 2017 filing shows 581 new, 526 increased, 430 reduced and 561 closed positions. Its largest new stake was Rockwell Collins: 63,879 shares worth $8.35M. The largest sale was Mobileye N.V., an estimated $25.8M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Communication Services.

  • Prelude Capital Management's largest Q3 2017 buy was Rockwell Collins: 63,879 shares worth $8.35M.
  • Prelude Capital Management added most to Calpine Corporation in Q3 2017, an estimated $12.6M increase.
  • Prelude Capital Management's biggest Q3 2017 reduction was Gray Television, cutting an estimated $14.3M.
  • Prelude Capital Management fully exited Mobileye N.V. in Q3 2017, selling an estimated $25.8M.
  • Prelude Capital Management's ten largest holdings make up 20% of its $1.11B portfolio in Q3 2017.
  • Prelude Capital Management opened 581 new positions and closed 561 in Q3 2017.
  • Prelude Capital Management's portfolio value rose 5% quarter-over-quarter to $1.11B.

Based on Prelude Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.